Current Controversies in Neoadjuvant Therapy for Pancreatic Cancer

Over the last two decades, there have been significant changes in the management of patients with localized pancreatic cancer. The rationale for an evolution toward a neoadjuvant approach and summary of relevant clinical trials is reviewed. Controversies in identifying optimal neoadjuvant therapeutic approaches are discussed.

Source: Surgical Oncology Clinics of North America - September 10, 2021 Category: Surgery Authors: Erin P. Ward, Herbert J. Zeh III, Susan Tsai Source Type: research